Yeji
FDA approvaloutcome: successconf 1.00

xphozah — FDA approval

$ARDX · ARDELYX, INC.
Event date
October 17, 2023
963 days ago
Sponsor runway
3 mo
$31.2M liquid

Evidence

openFDA ORIG (TYPE 10) approval of XPHOZAH 10 MG — application NDA213931

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

8 insiders · 0 buys · 29 sells
Sell10b5-1
2024-01-08
Rosenbaum David P.
Chief Development Officer
30,000 @ $6.64$199K
Sell10b5-1
2023-12-26
Renz Justin A
Chief Financial Officer
225,000 @ $6.36$1.43M
Exercise10b5-1
2023-12-26
Renz Justin A
Chief Financial Officer
75,000 @ $0.99$74K
Sell10b5-1
2023-12-18
Rosenbaum David P.
Chief Development Officer
5,675 @ $6.07$34K
Sell10b5-1
2023-12-14
Rosenbaum David P.
Chief Development Officer
7,000 @ $5.55$39K
Sell10b5-1
2023-12-11
GRAMMER ELIZABETH A
See Remarks
50,000 @ $5.08$254K
Sell10b5-1
2023-12-08
Rosenbaum David P.
Chief Development Officer
20,000 @ $5.27$105K
Sell10b5-1
2023-12-05
Rosenbaum David P.
Chief Development Officer
10,272 @ $5.00$51K
Sell10b5-1
2023-11-30
Rosenbaum David P.
Chief Development Officer
3,000 @ $4.50$14K
Sell
2023-11-20
Rodriguez Susan
Chief Commercial Officer
4,714 @ $4.36$21K
Sell
2023-11-20
Blanks Robert
See Remarks
2,835 @ $4.36$12K
Sell
2023-11-20
Rosenbaum David P.
Chief Development Officer
932 @ $4.36$4K
Sell
2023-11-20
Renz Justin A
Chief Financial Officer
2,873 @ $4.36$13K
Sell
2023-11-20
RAAB MICHAEL
President & CEO
11,368 @ $4.36$50K
Sell
2023-11-20
Felsch Robert Ora
See Remarks
1,044 @ $4.36$5K
Sell
2023-11-20
Williams Laura A
Chief Patient Officer
2,581 @ $4.36$11K
Sell
2023-11-20
Rosenbaum David P.
Chief Development Officer
2,835 @ $4.36$12K
Sell
2023-11-20
GRAMMER ELIZABETH A
See Remarks
2,384 @ $4.36$10K
Sell
2023-11-15
Williams Laura A
Chief Patient Officer
25,000 @ $4.00$100K
Sell10b5-1
2023-10-10
Rosenbaum David P.
Chief Development Officer
1,644 @ $4.00$7K
Sell10b5-1
2023-09-08
Rosenbaum David P.
Chief Development Officer
2,897 @ $4.55$13K
Sell
2023-08-21
Rosenbaum David P.
Chief Development Officer
937 @ $3.55$3K
Sell
2023-08-21
RAAB MICHAEL
President & CEO
11,419 @ $3.55$41K
Sell
2023-08-21
GRAMMER ELIZABETH A
See Remarks
2,392 @ $3.55$8K
Sell
2023-08-21
Blanks Robert
See Remarks
2,846 @ $3.55$10K
Sell
2023-08-21
Williams Laura A
Chief Patient Officer
2,591 @ $3.55$9K
Sell
2023-08-21
Rodriguez Susan
Chief Commercial Officer
4,733 @ $3.55$17K
Sell
2023-08-21
Renz Justin A
Chief Financial Officer
2,884 @ $3.55$10K
Sell
2023-08-21
Felsch Robert Ora
See Remarks
1,048 @ $3.55$4K
Sell
2023-08-21
Rosenbaum David P.
Chief Development Officer
2,846 @ $3.55$10K